Aperio Group, LLC - TARO PHARMACEUTICAL INDS LTD ownership

TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 95 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Aperio Group, LLC ownership history of TARO PHARMACEUTICAL INDS LTD
ValueSharesWeighting
Q4 2020$539,000
+23.9%
7,344
-7.3%
0.00%
+100.0%
Q3 2020$435,000
-39.5%
7,926
-26.7%
0.00%
-66.7%
Q2 2020$719,000
-17.4%
10,807
-24.0%
0.00%
-25.0%
Q1 2020$870,000
+6.6%
14,212
+53.1%
0.00%
+33.3%
Q4 2019$816,000
-36.8%
9,280
-45.8%
0.00%
-40.0%
Q3 2019$1,292,000
-15.7%
17,122
-4.6%
0.01%
-16.7%
Q2 2019$1,533,000
-21.4%
17,950
-0.5%
0.01%
-25.0%
Q1 2019$1,951,000
+19.0%
18,049
-6.9%
0.01%0.0%
Q4 2018$1,640,000
-23.8%
19,380
-11.5%
0.01%
-11.1%
Q3 2018$2,152,000
-3.5%
21,897
+13.7%
0.01%
-18.2%
Q2 2018$2,229,000
-13.3%
19,266
-26.0%
0.01%
-15.4%
Q1 2018$2,570,000
-55.6%
26,023
-52.9%
0.01%
-55.2%
Q4 2017$5,787,000
-1.2%
55,266
+6.4%
0.03%
-12.1%
Q3 2017$5,856,000
+2.8%
51,966
+2.2%
0.03%
-5.7%
Q2 2017$5,696,000
+41.2%
50,826
+46.9%
0.04%
+25.0%
Q1 2017$4,034,000
+93.1%
34,593
+74.3%
0.03%
+75.0%
Q4 2016$2,089,000
-59.8%
19,847
-57.8%
0.02%
-57.9%
Q3 2016$5,201,000
-30.0%
47,066
-7.7%
0.04%
-34.5%
Q2 2016$7,429,000
+518.1%
51,020
+508.2%
0.06%
+480.0%
Q1 2016$1,202,000
+295.4%
8,388
+326.4%
0.01%
+233.3%
Q4 2015$304,0001,9670.00%
Other shareholders
TARO PHARMACEUTICAL INDS LTD shareholders Q4 2019
NameSharesValueWeighting ↓
Claret Asset Management Corp 86,474$6,524,0001.34%
Analyst IMS Investment Management Services Ltd. 28,438$2,143,0000.64%
ALGERT GLOBAL LLC 20,876$1,575,0000.59%
Quantinno Capital Management LP 9,351$706,0000.48%
Crestline Management, LP 37,000$2,792,0000.45%
Empirical Finance, LLC 9,561$721,0000.20%
BRANDES INVESTMENT PARTNERS, LP 55,065$5,469,0000.14%
FORT, L.P. 9,672$730,0000.14%
CAXTON ASSOCIATES LP 8,865$669,0000.13%
ACADIAN ASSET MANAGEMENT LLC 330,448$24,928,0000.11%
View complete list of TARO PHARMACEUTICAL INDS LTD shareholders